Daiwa Securities Group
ABBV icon

Daiwa Securities Group’s AbbVie ABBV Stock Holding History

Daiwa Securities Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.1M Buy
363,737
+19,417
+6% +$4.31M 0.23% 68
2025
Q4 		$78.7M Buy
344,320
+7,698
+2% +$1.75M 0.25% 68
2025
Q3 		$77.9M Buy
336,622
+24,261
+8% +$4.94M 0.26% 63
2025
Q2 		$58M Buy
312,361
+38,862
+14% +$7.22M 0.21% 72
2025
Q1 		$57.3M Buy
273,499
+20,740
+8% +$4.03M 0.24% 68
2024
Q4 		$44.9M Buy
252,759
+27,937
+12% +$5.14M 0.2% 73
2024
Q3 		$44.4M Buy
224,822
+21,329
+10% +$3.98M 0.21% 72
2024
Q2 		$34.9M Buy
203,493
+10,904
+6% +$1.81M 0.19% 77
2024
Q1 		$35.1M Buy
192,589
+24,202
+14% +$4.17M 0.2% 76
2023
Q4 		$26.1M Buy
168,387
+11,775
+8% +$1.72M 0.16% 83
2023
Q3 		$23.3M Buy
156,612
+9,179
+6% +$1.35M 0.17% 85
2023
Q2 		$19.9M Buy
147,433
+3,890
+3% +$570K 0.13% 90
2023
Q1 		$22.9M Buy
143,543
+11,264
+9% +$1.72M 0.16% 77
2022
Q4 		$21.4M Buy
132,279
+8,437
+7% +$1.29M 0.16% 80
2022
Q3 		$16.6M Sell
123,842
-19,127
-13% -$2.74M 0.14% 85
2022
Q2 		$21.9M Buy
142,969
+7,909
+6% +$1.21M 0.17% 68
2022
Q1 		$21.9M Buy
135,060
+10,406
+8% +$1.51M 0.14% 83
2021
Q4 		$16.9M Buy
124,654
+22,195
+22% +$2.62M 0.1% 112
2021
Q3 		$11.1M Sell
102,459
-986
-1% -$113K 0.07% 141
2021
Q2 		$11.7M Sell
103,445
-20,653
-17% -$2.33M 0.08% 129
2021
Q1 		$13.4M Sell
124,098
-33,038
-21% -$3.53M 0.1% 99
2020
Q4 		$16.8M Buy
157,136
+61,056
+64% +$5.87M 0.13% 83
2020
Q3 		$8.42M Buy
96,080
+16,012
+20% +$1.51M 0.08% 117
2020
Q2 		$6.1M Hold
80,068
– – 0.13% 92
2020
Q1 		$6.1M Sell
80,068
-18,829
-19% -$1.6M 0.06% 144
2019
Q4 		$8.76M Buy
98,897
+4,923
+5% +$409K 0.07% 125
2019
Q3 		$7.12M Buy
93,974
+6,176
+7% +$423K 0.06% 148
2019
Q2 		$6.38M Buy
87,798
+12,000
+16% +$943K 0.06% 163
2019
Q1 		$6.11M Buy
75,798
+10,801
+17% +$884K 0.05% 155
2018
Q4 		$5.99M Buy
64,997
+980
+2% +$86.2K 0.06% 153
2018
Q3 		$6.05M Sell
64,017
-6,018
-9% -$571K 0.05% 191
2018
Q2 		$6.49M Buy
70,035
+1,050
+2% +$103K 0.05% 190
2018
Q1 		$6.53M Buy
68,985
+14,888
+28% +$1.64M 0.05% 193
2017
Q4 		$5.23M Sell
54,097
-12,870
-19% -$1.21M 0.04% 234
2017
Q3 		$5.95M Sell
66,967
-12,228
-15% -$931K 0.04% 201
2017
Q2 		$5.74M Sell
79,195
-4,400
-5% -$296K 0.04% 190
2017
Q1 		$5.45M Buy
83,595
+150
+0.2% +$9.43K 0.03% 201
2016
Q4 		$5.23M Buy
83,445
+12,900
+18% +$787K 0.03% 164
2016
Q3 		$4.45M Buy
70,545
+11,850
+20% +$767K 0.03% 181
2016
Q2 		$3.63M Buy
58,695
+20,600
+54% +$1.26M 0.02% 208
2016
Q1 		$2.18M Sell
38,095
-2,400
-6% -$134K 0.01% 272
2015
Q4 		$2.4M Sell
40,495
-2,500
-6% -$144K 0.02% 245
2015
Q3 		$2.34M Sell
42,995
-200
-0.5% -$13K 0.02% 241
2015
Q2 		$2.9M Buy
43,195
+1,395
+3% +$91.1K 0.02% 244
2015
Q1 		$2.45M Buy
41,800
+200
+0.5% +$12.1K 0.02% 250
2014
Q4 		$2.72M Sell
41,600
-3,300
-7% -$208K 0.02% 230
2014
Q3 		$2.59M Sell
44,900
-2,100
-4% -$117K 0.02% 199
2014
Q2 		$2.65M Sell
47,000
-400
-0.8% -$21K 0.02% 206
2014
Q1 		$2.44M Sell
47,400
-100
-0.2% -$5.05K 0.02% 213
2013
Q4 		$2.51M Sell
47,500
-4,200
-8% -$206K 0.02% 178
2013
Q3 		$2.31M Sell
51,700
-1,500
-3% -$66.5K 0.02% 204
2013
Q2 		$2.2M Buy
+53,200
New +$2.33M 0.02% 212

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Daiwa Securities Group's ABBV Position: Q1 2026 in Review

Daiwa Securities Group increased its AbbVie (ABBV) stake by 5.6% in Q1 2026, buying an estimated $4.31M and bringing the position to 363,737 shares worth $79.1M. The position accounts for 0.23% of the portfolio, ranked #68.

Daiwa Securities Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Daiwa Securities Group held 363,737 shares of AbbVie worth $79.1M as of Q1 2026.
  • Daiwa Securities Group bought 19,417 AbbVie shares in Q1 2026, an estimated $4.31M.
  • AbbVie made up 0.23% of Daiwa Securities Group's portfolio in Q1 2026, its #68 holding.
  • Daiwa Securities Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.